| NCT03176797 |
Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI |
https://ClinicalTrials.gov/show/NCT03176797 |
Enrolling by invitation |
Zhujiang Hospital |
2021-07-31 |
| NCT04060147 |
Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04060147 |
Recruiting |
Gilead Sciences |
2021-06-30 |
| NCT03957070 |
The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis |
https://ClinicalTrials.gov/show/NCT03957070 |
Recruiting |
Sonic Incytes |
2020-10-31 |
| NCT03407001 |
Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03407001 |
Recruiting |
M.D. Anderson Cancer Center |
2021-09-30 |
| NCT03388151 |
Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy |
https://ClinicalTrials.gov/show/NCT03388151 |
Recruiting |
Tanta University |
2022-11-11 |
| NCT03373396 |
Impact of Chlordecone on Active Chronic Hepatitis |
https://ClinicalTrials.gov/show/NCT03373396 |
Completed |
Centre Hospitalier Universitaire de Pointe-a-Pitre |
2015-12-21 |
| NCT03368066 |
Is Adrenal Insufficiency Under-diagnosed in Hospitalized Cirrhosis Patients? |
https://ClinicalTrials.gov/show/NCT03368066 |
Completed |
University of Virginia |
2019-03-12 |
| NCT03826433 |
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells（19#iSCLife®-LC） in the Treatment of Decompensated Hepatitis b Cirrhosis |
https://ClinicalTrials.gov/show/NCT03826433 |
Recruiting |
Sclnow Biotechnology Co., Ltd. |
2020-06-30 |
| NCT03871894 |
Indirect Calorimeter Based Study in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03871894 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2021-01-31 |
| NCT03363412 |
Tips Underdilatation in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03363412 |
Completed |
University of Modena and Reggio Emilia |
2012-12-31 |
| NCT03354299 |
Effect of Coconut Milk Supplementation to Improve Nutritional Status in Cirrhosis Patient |
https://ClinicalTrials.gov/show/NCT03354299 |
Completed |
Dr Cipto Mangunkusumo General Hospital |
2014-07-31 |
| NCT03342560 |
Beyond Confounders: Addressing Source of Measurement Variability and Error in Shear Wave Elastography |
https://ClinicalTrials.gov/show/NCT03342560 |
Completed |
Massachusetts General Hospital |
2018-08-14 |
| NCT03339232 |
BCAA Supplemental Study |
https://ClinicalTrials.gov/show/NCT03339232 |
Completed |
Loyola University |
2019-06-17 |
| NCT03337945 |
In Vivo Determination of Cytochrome P450 Activities in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03337945 |
Recruiting |
University Hospital, Basel, Switzerland |
2019-12-31 |
| NCT03318380 |
Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03318380 |
Recruiting |
Thomas Jefferson University |
2020-07-31 |
| NCT03311152 |
Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03311152 |
Recruiting |
Central Hospital, Nancy, France |
2021-02-12 |
| NCT03285217 |
HMB for Denutrition in Patients With Cirrhosis (HEPATIC) |
https://ClinicalTrials.gov/show/NCT03285217 |
Active, not recruiting |
Instituto Aragones de Ciencias de la Salud |
2018-03-31 |
| NCT03278925 |
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03278925 |
Recruiting |
National Cancer Institute (NCI) |
2021-01-15 |
| NCT03254758 |
A Study of ADR-001 in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03254758 |
Recruiting |
Rohto Pharmaceutical Co., Ltd. |
2019-12-31 |
| NCT03235349 |
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection |
https://ClinicalTrials.gov/show/NCT03235349 |
Completed |
AbbVie |
2018-11-15 |
| NCT03219372 |
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence |
https://ClinicalTrials.gov/show/NCT03219372 |
Recruiting |
Cedars-Sinai Medical Center |
2021-06-01 |
| NCT03208868 |
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03208868 |
Recruiting |
The Cleveland Clinic |
2020-12-31 |
| NCT03205345 |
Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis |
https://ClinicalTrials.gov/show/NCT03205345 |
Active, not recruiting |
Conatus Pharmaceuticals Inc. |
2019-08-31 |
| NCT03202498 |
Safety and Tolerability of Yaq-001 in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03202498 |
Recruiting |
Yaqrit Ltd |
2020-08-30 |
| NCT03191851 |
Evaluation of ‘Melody’ Paracentesis Device for Ascites Therapy |
https://ClinicalTrials.gov/show/NCT03191851 |
Completed |
University of Nottingham |
2019-01-10 |
| NCT03176966 |
Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03176966 |
Enrolling by invitation |
Vanderbilt University Medical Center |
2022-06-30 |
| NCT03172273 |
Early Use of TIPS With Polytetrafluoroethylene(PTFE) Covered Stents in Cirrhotic Patients With Refractory Ascites |
https://ClinicalTrials.gov/show/NCT03172273 |
Recruiting |
Fourth Military Medical University |
2022-09-18 |
| NCT03171805 |
The Use of Propranolol for the Prevention of Worsening of Esophageal Varices in Patients With Isolated Gastric Varices |
https://ClinicalTrials.gov/show/NCT03171805 |
Recruiting |
West China Hospital |
2020-05-15 |
| NCT03171727 |
Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction |
https://ClinicalTrials.gov/show/NCT03171727 |
Recruiting |
West China Hospital |
2019-05-15 |
| NCT03139058 |
Prevalence of Liver Fibrosis and Cirrhosis in Patients With Squamous Cell Carcinoma of the Head and Neck |
https://ClinicalTrials.gov/show/NCT03139058 |
Recruiting |
Centre Hospitalier Universitaire, Amiens |
2019-06-20 |
| NCT03152188 |
Oral Fecal Transplant in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03152188 |
Completed |
Virginia Commonwealth University |
2018-11-12 |
| NCT03150459 |
Simvastatin Plus Rifaximin in Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT03150459 |
Completed |
Institut d’Investigacions Biomèdiques August Pi i Sunyer |
2018-03-12 |
| NCT03144713 |
Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03144713 |
Completed |
Institute of Liver and Biliary Sciences, India |
2018-04-30 |
| NCT03123666 |
Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03123666 |
Active, not recruiting |
Institute of Liver and Biliary Sciences, India |
2020-10-19 |
| NCT03120637 |
Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene Blue |
https://ClinicalTrials.gov/show/NCT03120637 |
Completed |
Institute of Liver and Biliary Sciences, India |
2018-01-10 |
| NCT03109236 |
Autologous Endothelial Progenitor Cell Therapy for Reversal of Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03109236 |
Recruiting |
National University Hospital, Singapore |
2020-03-31 |
| NCT03107091 |
Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites |
https://ClinicalTrials.gov/show/NCT03107091 |
Completed |
BioVie Inc. |
2019-04-01 |
| NCT03089944 |
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT03089944 |
Completed |
AbbVie |
2019-07-31 |
| NCT03087344 |
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis |
https://ClinicalTrials.gov/show/NCT03087344 |
Completed |
VA Connecticut Healthcare System |
2018-06-30 |
| NCT03070353 |
Dextran, a Plasma Expander, Offers New Hope for Patients With Decompensated Liver Cirrhosis and Acute Kidney Injury |
https://ClinicalTrials.gov/show/NCT03070353 |
Completed |
Ramathibodi Hospital |
2016-06-30 |
| NCT03069339 |
Carvedilol, Endoscopic Variceal Ligation or Combination of Both for Prevention of First Variceal Bleed in Child’s B & C Cirrhosis |
https://ClinicalTrials.gov/show/NCT03069339 |
Active, not recruiting |
Institute of Liver and Biliary Sciences, India |
2020-11-30 |
| NCT03059446 |
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03059446 |
Enrolling by invitation |
Tobira Therapeutics, Inc. |
2029-11-27 |
| NCT03059030 |
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia |
https://ClinicalTrials.gov/show/NCT03059030 |
Recruiting |
Northwestern University |
2020-04-01 |
| NCT03047707 |
S-Shearwave Elastography for Assessment of Hepatic Fibrosis |
https://ClinicalTrials.gov/show/NCT03047707 |
Completed |
Seoul National University Hospital |
2018-04-24 |
| NCT03030820 |
Oral Gut Liver Axis in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03030820 |
Completed |
Virginia Commonwealth University |
2018-03-31 |
| NCT03018990 |
Alcohol Challenge On Liver and Gut Measured by Liver Vein Catheterization. A Pathophysiological Intervention Trial |
https://ClinicalTrials.gov/show/NCT03018990 |
Active, not recruiting |
Odense University Hospital |
2018-11-12 |
| NCT03005444 |
Anticoagulation for Advanced Cirrhotic Patients After TIPS |
https://ClinicalTrials.gov/show/NCT03005444 |
Recruiting |
Fourth Military Medical University |
2020-12-31 |
| NCT02996682 |
Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02996682 |
Completed |
Gilead Sciences |
2018-02-13 |
| NCT02968810 |
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT02968810 |
Recruiting |
National Cancer Institute (NCI) |
2021-04-14 |
| NCT02967198 |
Pre-procedure Planning for Liver Biopsy or Radiofrequency Ablation Using CT or MR/US Fusing Imaging |
https://ClinicalTrials.gov/show/NCT02967198 |
Completed |
Seoul National University Hospital |
2016-09-30 |
| NCT02965131 |
The Effects of the Anhepatic Phase Extended by Temporary Portocaval Shunt on Anesthetic Sensitivity and Cognitive Function |
https://ClinicalTrials.gov/show/NCT02965131 |
Completed |
Daegu Catholic University Medical Center |
2016-01-31 |
| NCT02960204 |
Emricasan, an Oral Caspase Inhibitor, in Subjects With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis and Severe Portal Hypertension |
https://ClinicalTrials.gov/show/NCT02960204 |
Completed |
Conatus Pharmaceuticals Inc. |
2018-10-02 |
| NCT02957253 |
Effects on Liver Cirrhotic Patients’ by a Nurse-led Clinic |
https://ClinicalTrials.gov/show/NCT02957253 |
Recruiting |
Uppsala University |
2022-12-31 |
| NCT02949505 |
Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation |
https://ClinicalTrials.gov/show/NCT02949505 |
Completed |
University of Birmingham |
2017-10-01 |
| NCT02944643 |
Mindfulness and Support Group to Improve Patient and Caregiver Burden in Cirrhosis |
https://ClinicalTrials.gov/show/NCT02944643 |
Completed |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2017-01-31 |
| NCT02936596 |
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome |
https://ClinicalTrials.gov/show/NCT02936596 |
Recruiting |
West China Hospital |
2020-06-01 |
| NCT02923336 |
Evaluation of Gastrointestinal Transit Pre and Pos Treatment With Non Selective Betablocker in a Population of Cirrhotics |
https://ClinicalTrials.gov/show/NCT02923336 |
Recruiting |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2019-01-31 |
| NCT02907749 |
Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis |
https://ClinicalTrials.gov/show/NCT02907749 |
Active, not recruiting |
Shanghai Tongji Hospital, Tongji University School of Medicine |
2020-06-01 |
| NCT02862249 |
Trial of Faecal Microbiota Transplantation in Cirrhosis |
https://ClinicalTrials.gov/show/NCT02862249 |
Recruiting |
King’s College London |
2020-05-31 |
| NCT02859610 |
Microparticles in Cirrhosis and Portal Hypertension |
https://ClinicalTrials.gov/show/NCT02859610 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2015-01-31 |
| NCT02854241 |
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance |
https://ClinicalTrials.gov/show/NCT02854241 |
Active, not recruiting |
Seoul National University Hospital |
2020-09-30 |
| NCT02849132 |
Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients |
https://ClinicalTrials.gov/show/NCT02849132 |
Active, not recruiting |
Beijing Friendship Hospital |
2020-12-31 |
| NCT02837939 |
Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction |
https://ClinicalTrials.gov/show/NCT02837939 |
Recruiting |
Pavol Jozef Safarik University |
2020-07-31 |
| NCT02811887 |
SMS-based Lifestyle Intervention for Patients With Liver Cirrhosis With Previous Hepathic Encephalopathy |
https://ClinicalTrials.gov/show/NCT02811887 |
Recruiting |
Frederiksberg University Hospital |
2022-10-31 |
| NCT02802228 |
Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT02802228 |
Completed |
Cumberland Pharmaceuticals |
2018-07-17 |
| NCT02786017 |
Injectable Collagen Scaffoldâ„¢ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02786017 |
Recruiting |
Chinese Academy of Sciences |
2020-12-31 |
| NCT02778425 |
The Treatment of Hepatocirrhosis and Portal Hypertension |
https://ClinicalTrials.gov/show/NCT02778425 |
Recruiting |
Qilu Hospital of Shandong University |
2019-02-28 |
| NCT02705534 |
Sofosbuvir, Ledipasvir, Ribavirin for Hepatitis C Cirrhotics, Genotype 1 |
https://ClinicalTrials.gov/show/NCT02705534 |
Completed |
Tehran University of Medical Sciences |
2017-09-30 |
| NCT02702739 |
Sofosbuvir/Simeprevir Plus a Flat Dose of Ribavirin in Genotype 1 Elderly HCV Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT02702739 |
Completed |
Azienda Ospedaliera San Camillo Forlanini |
2015-12-31 |
| NCT02695628 |
[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer |
https://ClinicalTrials.gov/show/NCT02695628 |
Completed |
Stanford University |
2018-04-30 |
| NCT02669875 |
Serelaxin To Lower Portal Pressure |
https://ClinicalTrials.gov/show/NCT02669875 |
Completed |
University of Edinburgh |
2018-08-31 |
| NCT02642874 |
Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT02642874 |
Recruiting |
Tanta University |
2020-12-31 |
| NCT02642003 |
To Assess the Efficacy of Granulocyte Colony Stimulating Factor Versus Standard Medical Therapy in Patients of Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02642003 |
Completed |
Sir Ganga Ram Hospital |
2016-01-31 |
| NCT02636647 |
Fecal Transplant in Recurrent Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT02636647 |
Completed |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2016-08-31 |
| NCT02608658 |
Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites |
https://ClinicalTrials.gov/show/NCT02608658 |
Completed |
St. Louis University |
2017-04-27 |
| NCT02603666 |
Elastography of the Liver in Cystic Fibrosis Patients. Diagnostic and Prognostic Aspects |
https://ClinicalTrials.gov/show/NCT02603666 |
Completed |
Karolinska University Hospital |
2014-06-30 |
| NCT02597166 |
Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection |
https://ClinicalTrials.gov/show/NCT02597166 |
Completed |
University Health Network, Toronto |
2018-06-30 |
| NCT02596880 |
Sofosbuvir, Daclatasvir, Ribavirin for Hepatitis C Virus (HCV) Cirrhotics |
https://ClinicalTrials.gov/show/NCT02596880 |
Completed |
Tehran University of Medical Sciences |
2016-04-30 |
| NCT04365868 |
Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis |
https://ClinicalTrials.gov/show/NCT04365868 |
Recruiting |
Galectin Therapeutics Inc. |
2023-06-30 |
| NCT02557360 |
Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT02557360 |
Completed |
Pomeranian Medical University Szczecin |
2017-02-28 |
| NCT02538874 |
A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body |
https://ClinicalTrials.gov/show/NCT02538874 |
Completed |
Bristol-Myers Squibb |
2016-11-04 |
| NCT02528760 |
To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis |
https://ClinicalTrials.gov/show/NCT02528760 |
Completed |
Institute of Liver and Biliary Sciences, India |
2017-08-31 |
| NCT02517528 |
ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02517528 |
Completed |
AbbVie |
2016-09-29 |
| NCT02508688 |
Thoracoscopic Mesh Repair of Diaphragmatic Defects for Hepatic Hydrothorax |
https://ClinicalTrials.gov/show/NCT02508688 |
Completed |
National Taiwan University Hospital |
2014-12-31 |
| NCT02508298 |
Surrogate Markers of Portal Pressure |
https://ClinicalTrials.gov/show/NCT02508298 |
Completed |
VA Connecticut Healthcare System |
2018-07-31 |
| NCT02485184 |
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis |
https://ClinicalTrials.gov/show/NCT02485184 |
Recruiting |
Fourth Military Medical University |
2021-12-31 |
| NCT02484573 |
Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol) |
https://ClinicalTrials.gov/show/NCT02484573 |
Recruiting |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2020-01-31 |
| NCT02475928 |
Zinc Supplementation in Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT02475928 |
Recruiting |
Fundación ClÃnica Médica Sur |
2019-12-31 |
| NCT02468063 |
To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock |
https://ClinicalTrials.gov/show/NCT02468063 |
Completed |
Institute of Liver and Biliary Sciences, India |
2017-05-31 |
| NCT02462967 |
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis |
https://ClinicalTrials.gov/show/NCT02462967 |
Completed |
Galectin Therapeutics Inc. |
2017-10-31 |
| NCT02462902 |
Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension |
https://ClinicalTrials.gov/show/NCT02462902 |
Completed |
Institute of Liver and Biliary Sciences, India |
2015-06-30 |
| NCT02457403 |
Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy: Rotational Thromboelastometry Versus Conventional Therapy |
https://ClinicalTrials.gov/show/NCT02457403 |
Completed |
Ohio State University |
2018-11-30 |
| NCT02451033 |
Granulocyte Colony Stimulating Factor And Growth Hormone In Cirrhosis Of Liver: An Open Label Study |
https://ClinicalTrials.gov/show/NCT02451033 |
Completed |
Postgraduate Institute of Medical Education and Research |
2016-06-30 |
| NCT02439567 |
Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C) |
https://ClinicalTrials.gov/show/NCT02439567 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2016-07-31 |
| NCT02423395 |
Study of Orphenadrine` in the Treatment of Muscle Cramps in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT02423395 |
Recruiting |
Tanta University |
2028-12-31 |
| NCT02421094 |
Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis |
https://ClinicalTrials.gov/show/NCT02421094 |
Completed |
Galectin Therapeutics Inc. |
2016-09-27 |
| NCT02414880 |
Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection |
https://ClinicalTrials.gov/show/NCT02414880 |
Completed |
Cairo University |
2015-08-31 |
| NCT02377141 |
Early Use of TIPSS in Patients With Cirrhosis and Variceal Bleeding |
https://ClinicalTrials.gov/show/NCT02377141 |
Completed |
University of Edinburgh |
2019-01-31 |
| NCT02376335 |
B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT02376335 |
Completed |
Newcastle-upon-Tyne Hospitals NHS Trust |
2016-03-31 |
| NCT02367092 |
Exercise Intervention in Liver Transplant Patients |
https://ClinicalTrials.gov/show/NCT02367092 |
Completed |
University of California, San Francisco |
2019-12-31 |
| NCT02362178 |
Thromboelastographic Guide for Blood Products in Cirrhotics |
https://ClinicalTrials.gov/show/NCT02362178 |
Completed |
University of Modena and Reggio Emilia |
2014-08-31 |
| NCT02344719 |
Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT02344719 |
Completed |
Medical University of Vienna |
2015-05-31 |
| NCT02308111 |
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis |
https://ClinicalTrials.gov/show/NCT02308111 |
Recruiting |
Intercept Pharmaceuticals |
2024-12-31 |
| NCT02297867 |
Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT02297867 |
Completed |
Gwo Xi Stem Cell Applied Technology Co., Ltd. |
2017-12-18 |
| NCT02273362 |
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver |
https://ClinicalTrials.gov/show/NCT02273362 |
Active, not recruiting |
National Cancer Institute (NCI) |
2020-02-11 |
| NCT02265484 |
To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism |
https://ClinicalTrials.gov/show/NCT02265484 |
Completed |
Institute of Liver and Biliary Sciences, India |
2015-01-31 |
| NCT02265237 |
A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) |
https://ClinicalTrials.gov/show/NCT02265237 |
Completed |
AbbVie |
2016-07-28 |
| NCT02256514 |
Open Label Trial of Immunotherapy for Advanced Liver Cancer |
https://ClinicalTrials.gov/show/NCT02256514 |
Enrolling by invitation |
Immunitor LLC |
2019-09-30 |
| NCT02254434 |
A Pharmacokinetic Study of Eltrombopag 50 Milligram (mg) in Healthy Volunteers Under Fasting Conditions |
https://ClinicalTrials.gov/show/NCT02254434 |
Completed |
GlaxoSmithKline |
2014-09-08 |
| NCT02249741 |
Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate Supplementation |
https://ClinicalTrials.gov/show/NCT02249741 |
Completed |
Sir Ganga Ram Hospital |
2014-02-28 |
| NCT02241616 |
Traditional Chinese Medicine Combined With Entecavir to Treat Refractory Liver Fibrosis in Liver Cirrhosis Due to HBV |
https://ClinicalTrials.gov/show/NCT02241616 |
Recruiting |
ShuGuang Hospital |
2019-06-30 |
| NCT02241590 |
Treatment of Liver Cirrhosis Due to Hepatitis B Virus With Fuzheng Huayu and Entecavir |
https://ClinicalTrials.gov/show/NCT02241590 |
Recruiting |
ShuGuang Hospital |
2019-06-30 |
| NCT02234440 |
Effect of Metformin on Disease Progression in Patients With Cryptogenic Cirrhosis (NASH-related Cirrhosis) With Diabetes or Impaired Glucose Tolerance or Insulin Resistance |
https://ClinicalTrials.gov/show/NCT02234440 |
Completed |
Institute of Liver and Biliary Sciences, India |
2015-12-31 |
| NCT02230683 |
A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension |
https://ClinicalTrials.gov/show/NCT02230683 |
Completed |
Conatus Pharmaceuticals Inc. |
2015-05-31 |
| NCT02230670 |
A Study of IDN-6556 in Subjects With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT02230670 |
Completed |
Conatus Pharmaceuticals Inc. |
2016-01-31 |
| NCT02226939 |
Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Cirrhosis and Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT02226939 |
Completed |
Boehringer Ingelheim |
2002-11-30 |
| NCT02224456 |
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02224456 |
Active, not recruiting |
GlaxoSmithKline |
2020-12-02 |
| NCT02219503 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis |
https://ClinicalTrials.gov/show/NCT02219503 |
Completed |
AbbVie |
2015-06-30 |
| NCT02219477 |
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02219477 |
Completed |
AbbVie |
2016-06-13 |
| NCT02217475 |
Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT02217475 |
Completed |
Tobira Therapeutics, Inc. |
2016-06-30 |
| NCT02201901 |
Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis |
https://ClinicalTrials.gov/show/NCT02201901 |
Completed |
Gilead Sciences |
2015-08-31 |
| NCT02195440 |
An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis |
https://ClinicalTrials.gov/show/NCT02195440 |
Completed |
Komagome Hospital |
2017-03-31 |
| NCT02173288 |
Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites |
https://ClinicalTrials.gov/show/NCT02173288 |
Completed |
Postgraduate Institute of Medical Education and Research |
2016-03-31 |
| NCT02156232 |
Embolization of Large Spontaneous Portosystemic Shunts for the Prevention of Post-TIPS Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT02156232 |
Recruiting |
Fourth Military Medical University |
2020-12-31 |
| NCT02151864 |
LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis |
https://ClinicalTrials.gov/show/NCT02151864 |
Completed |
University of California, San Diego |
2016-12-31 |
| NCT02143778 |
Assessing Portal Hypertension With Methacetin Breath Test |
https://ClinicalTrials.gov/show/NCT02143778 |
Completed |
Exalenz Bioscience LTD. |
2018-12-31 |
| NCT02138253 |
A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV |
https://ClinicalTrials.gov/show/NCT02138253 |
Completed |
Conatus Pharmaceuticals Inc. |
2018-02-15 |
| NCT02135536 |
Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT02135536 |
Completed |
NGM Biopharmaceuticals, Inc |
2016-02-29 |
| NCT02134626 |
Simvastatin Effect on Portal Hypertension |
https://ClinicalTrials.gov/show/NCT02134626 |
Completed |
Universidade Federal do Rio de Janeiro |
2014-04-30 |
| NCT02132962 |
Sarcopenia and Cirrhosis |
https://ClinicalTrials.gov/show/NCT02132962 |
Completed |
Rigshospitalet, Denmark |
2015-10-31 |
| NCT02120196 |
Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis |
https://ClinicalTrials.gov/show/NCT02120196 |
Recruiting |
Tanta University |
2023-12-31 |
| NCT02119988 |
TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT02119988 |
Recruiting |
Fourth Military Medical University |
2020-12-31 |
| NCT02114177 |
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis |
https://ClinicalTrials.gov/show/NCT02114177 |
Completed |
Janssen Infectious Diseases BVBA |
2015-01-31 |
| NCT02114151 |
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis |
https://ClinicalTrials.gov/show/NCT02114151 |
Completed |
Janssen Infectious Diseases BVBA |
2015-01-31 |
| NCT02085915 |
Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the Cirrhosis |
https://ClinicalTrials.gov/show/NCT02085915 |
Completed |
Centre Hospitalier Departemental Vendee |
2015-08-31 |
| NCT02068339 |
Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT02068339 |
Completed |
PharmaKing |
2016-02-29 |
| NCT01298271 |
A Randomized Trial of GVS Alone vs. Propranolol |
https://ClinicalTrials.gov/show/NCT01298271 |
Recruiting |
Taipei Veterans General Hospital, Taiwan |
2025-12-31 |
| NCT01289951 |
Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis |
https://ClinicalTrials.gov/show/NCT01289951 |
Completed |
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal |
2011-06-30 |
| NCT01288794 |
Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis |
https://ClinicalTrials.gov/show/NCT01288794 |
Completed |
University of Bologna |
2014-11-30 |
| NCT01283152 |
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy. |
https://ClinicalTrials.gov/show/NCT01283152 |
Completed |
University of Texas Southwestern Medical Center |
2012-06-30 |
| NCT01271660 |
A Study Evaluating the Efficacy and Safety of Pregabalin Against Frequent Muscle Cramp in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01271660 |
Completed |
Seoul National University Boramae Hospital |
2018-02-28 |
| NCT02023229 |
Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT02023229 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2013-01-31 |
| NCT02041780 |
Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy |
https://ClinicalTrials.gov/show/NCT02041780 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2016-05-31 |
| NCT02028949 |
Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study |
https://ClinicalTrials.gov/show/NCT02028949 |
Completed |
Centre Hospitalier Universitaire Dijon |
2015-11-30 |
| NCT02026401 |
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT02026401 |
Completed |
NGM Biopharmaceuticals, Inc |
2014-12-31 |
| NCT02019784 |
Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT02019784 |
Completed |
King’s College Hospital NHS Trust |
2016-06-30 |
| NCT04065841 |
Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin Compared to Each Monotherapy, in Adult Patients With NASH and Liver Fibrosis. |
https://ClinicalTrials.gov/show/NCT04065841 |
Recruiting |
Novartis |
2022-03-15 |
| NCT01951209 |
Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In Cirrhosis |
https://ClinicalTrials.gov/show/NCT01951209 |
Active, not recruiting |
Corporal Michael J. Crescenz VA Medical Center |
2018-08-31 |
| NCT01943617 |
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01943617 |
Completed |
Beijing Friendship Hospital |
2016-12-31 |
| NCT01938820 |
Optimized Treatment and Regression of HBV-induced Early Cirrhosis |
https://ClinicalTrials.gov/show/NCT01938820 |
Completed |
Beijing Friendship Hospital |
2016-12-31 |
| NCT01938781 |
Optimized Treatment and Regression of HBV-induced Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01938781 |
Completed |
Beijing Friendship Hospital |
2016-12-31 |
| NCT01935817 |
Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV |
https://ClinicalTrials.gov/show/NCT01935817 |
Completed |
University of Catania |
2012-12-31 |
| NCT01934777 |
Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT01934777 |
Completed |
Bambino Gesù Hospital and Research Institute |
2014-10-31 |
| NCT01909778 |
Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01909778 |
Completed |
Boehringer Ingelheim |
2008-10-31 |
| NCT01905254 |
Transient Elastography in Autoimmune Hepatitis |
https://ClinicalTrials.gov/show/NCT01905254 |
Completed |
Universitätsklinikum Hamburg-Eppendorf |
2010-08-31 |
| NCT01904409 |
Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01904409 |
Completed |
Bausch Health Americas, Inc. |
2015-06-30 |
| NCT01904058 |
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01904058 |
Completed |
Mirum Pharmaceuticals, Inc. |
2015-04-30 |
| NCT01902511 |
A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis. |
https://ClinicalTrials.gov/show/NCT01902511 |
Completed |
Institute of Liver and Biliary Sciences, India |
2015-12-31 |
| NCT01899703 |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus |
https://ClinicalTrials.gov/show/NCT01899703 |
Completed |
GlaxoSmithKline |
2015-10-07 |
| NCT01888900 |
New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01888900 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-11-30 |
| NCT01884415 |
Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis |
https://ClinicalTrials.gov/show/NCT01884415 |
Completed |
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla |
2017-12-31 |
| NCT01875081 |
REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) |
https://ClinicalTrials.gov/show/NCT01875081 |
Completed |
Pharmicell Co., Ltd. |
2016-03-31 |
| NCT01865812 |
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01865812 |
Completed |
Intercept Pharmaceuticals |
2014-08-31 |
| NCT01857284 |
Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01857284 |
Completed |
Beijing Friendship Hospital |
2013-01-31 |
| NCT01836224 |
Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit |
https://ClinicalTrials.gov/show/NCT01836224 |
Completed |
Institute of Liver and Biliary Sciences, India |
2014-09-30 |
| NCT01804829 |
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. |
https://ClinicalTrials.gov/show/NCT01804829 |
Completed |
Biotest Pharmaceuticals Corporation |
2016-02-29 |
| NCT01799785 |
Effects of Aerobic Training on Exercise Capacity in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT01799785 |
Completed |
University of Alberta |
2013-07-31 |
| NCT01789008 |
Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease. |
https://ClinicalTrials.gov/show/NCT01789008 |
Completed |
Rennes University Hospital |
2017-06-19 |
| NCT01781208 |
Ultrasound Based Acoustic Radiation Force Impulse Imaging |
https://ClinicalTrials.gov/show/NCT01781208 |
Completed |
University of Michigan |
2015-05-31 |
| NCT01773538 |
Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement |
https://ClinicalTrials.gov/show/NCT01773538 |
Completed |
Hospital of South West Jutland |
2015-10-31 |
| NCT01769040 |
Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT01769040 |
Completed |
Copenhagen University Hospital, Hvidovre |
2016-01-31 |
| NCT01767597 |
Application of HBV Rapid Tests as a Tool for Wide-Use Screening |
https://ClinicalTrials.gov/show/NCT01767597 |
Completed |
Institut de Médecine et d’Epidémiologie Appliquée - Fondation Internationale Léon M’Ba |
2012-07-31 |
| NCT01762748 |
Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant |
https://ClinicalTrials.gov/show/NCT01762748 |
Completed |
Federal University of Minas Gerais |
2012-12-31 |
| NCT01747772 |
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01747772 |
Completed |
Massachusetts General Hospital |
2014-02-14 |
| NCT01735591 |
Administration of Probiotics in Cirrhotic Patients Listed for Liver Transplantation |
https://ClinicalTrials.gov/show/NCT01735591 |
Completed |
Medical University of Warsaw |
2015-11-30 |
| NCT01722578 |
L-ornithine L-aspartate in Overt Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT01722578 |
Completed |
Dayanand Medical College and Hospital |
2017-01-31 |
| NCT01713478 |
Subclinical Myocardial Dysfunction in Patients With Hepatic Cirrhosis |
https://ClinicalTrials.gov/show/NCT01713478 |
Completed |
Carol Davila University of Medicine and Pharmacy |
2014-12-31 |
| NCT01707472 |
Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01707472 |
Completed |
Gilead Sciences |
2014-10-17 |
| NCT01704755 |
A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT01704755 |
Completed |
AbbVie |
2014-01-31 |
| NCT01687257 |
Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation |
https://ClinicalTrials.gov/show/NCT01687257 |
Completed |
Gilead Sciences |
2015-01-31 |
| NCT01686698 |
Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT01686698 |
Completed |
Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau |
2014-03-31 |
| NCT01676285 |
Metoprolol Succinate in Cardiac Remodeling Related to Cirrhosis |
https://ClinicalTrials.gov/show/NCT01676285 |
Completed |
University of Sao Paulo |
2013-09-30 |
| NCT01640964 |
An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension |
https://ClinicalTrials.gov/show/NCT01640964 |
Completed |
Novartis |
2014-12-31 |
| NCT01618890 |
Hepatic Venous Pressure Gradient-guided Versus Standard Beta-blocker Therapy in Primary Prevention of Variceal Bleeding |
https://ClinicalTrials.gov/show/NCT01618890 |
Recruiting |
Leiden University Medical Center |
2020-12-31 |
| NCT01614405 |
Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01614405 |
Completed |
University of Alberta |
2015-07-31 |
| NCT01607528 |
Influence of Probiotics on Infections in Cirrhosis |
https://ClinicalTrials.gov/show/NCT01607528 |
Completed |
Medical University of Graz |
2014-03-31 |
| NCT01603199 |
High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01603199 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2015-07-31 |
| NCT01600105 |
Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI) |
https://ClinicalTrials.gov/show/NCT01600105 |
Completed |
Icahn School of Medicine at Mount Sinai |
2017-07-31 |
| NCT01598064 |
Probiotics for Liver Cirrhosis With Portal Hypertension |
https://ClinicalTrials.gov/show/NCT01598064 |
Completed |
National Cheng-Kung University Hospital |
2013-08-31 |
| NCT01591200 |
Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01591200 |
Completed |
Stempeutics Research Pvt Ltd |
2016-04-30 |
| NCT01575574 |
Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis |
https://ClinicalTrials.gov/show/NCT01575574 |
Completed |
Fundacion Clinic per a la Recerca Biomédica |
2016-07-31 |
| NCT01572064 |
Magnetic Resonance Imaging in the Evaluation of Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01572064 |
Completed |
University of Nottingham |
2012-09-30 |
| NCT01556646 |
Effect of Tolvaptan on Cognitive Function in Cirrhosis |
https://ClinicalTrials.gov/show/NCT01556646 |
Completed |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2013-06-30 |
| NCT04321031 |
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) |
https://ClinicalTrials.gov/show/NCT04321031 |
Recruiting |
Pfizer |
2022-11-01 |
| NCT01537965 |
Evaluation of Innovative Ultrasonic Techniques for Non-invasive Diagnosis of Liver Fibrosis in Patients With Chronic Viral Hepatitis B or C |
https://ClinicalTrials.gov/show/NCT01537965 |
Completed |
University Hospital, Grenoble |
2014-01-31 |
| NCT01510860 |
Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01510860 |
Completed |
Dr. Falk Pharma GmbH |
2010-07-31 |
| NCT01509391 |
Keyhole Limpet Hemocyanin in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT01509391 |
Completed |
Medical University of Graz |
2012-10-31 |
| NCT01503749 |
Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01503749 |
Completed |
Seoul National University Hospital |
2013-07-31 |
| NCT01495403 |
Treatment of Muscle Cramps in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01495403 |
Completed |
Mayo Clinic |
2015-04-30 |
| NCT01473524 |
Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01473524 |
Completed |
Intercept Pharmaceuticals |
2013-12-31 |
| NCT01463956 |
Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation |
https://ClinicalTrials.gov/show/NCT01463956 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2014-06-30 |
| NCT01463735 |
Vitamin E Supplement in Patients With Cirrhosis and Acanthocytosis |
https://ClinicalTrials.gov/show/NCT01463735 |
Completed |
University Hospital, Geneva |
2013-05-31 |
| NCT01458990 |
Proton Pump Inhibitors and Dysbiosis in Cirrhosis |
https://ClinicalTrials.gov/show/NCT01458990 |
Completed |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2018-02-28 |
| NCT00006168 |
Ursodiol-Methotrexate for Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00006168 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT01456286 |
Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension |
https://ClinicalTrials.gov/show/NCT01456286 |
Completed |
Fundacion Clinic per a la Recerca Biomédica |
2013-10-31 |
| NCT01454336 |
Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone |
https://ClinicalTrials.gov/show/NCT01454336 |
Completed |
Royan Institute |
2013-07-31 |
| NCT01452308 |
Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT01452308 |
Completed |
Gilead Sciences |
2013-01-31 |
| NCT01447667 |
Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) |
https://ClinicalTrials.gov/show/NCT01447667 |
Recruiting |
Seoul National University Hospital |
2021-12-31 |
| NCT01447537 |
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT01447537 |
Completed |
Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau |
2012-06-30 |
| NCT01434108 |
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding |
https://ClinicalTrials.gov/show/NCT01434108 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2015-03-31 |
| NCT01409356 |
Effects of Weight Loss on Portal Pressure in Patients With Overweight/Obesity and Cirrhosis |
https://ClinicalTrials.gov/show/NCT01409356 |
Completed |
Hospital Clinic of Barcelona |
2014-02-28 |
| NCT01408966 |
Effects of Dark vs. White Chocolate on the Postprandial Increase in Portal Pressure in Cirrhosis |
https://ClinicalTrials.gov/show/NCT01408966 |
Completed |
Hospital Clinic of Barcelona |
2008-10-31 |
| NCT01389973 |
A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid |
https://ClinicalTrials.gov/show/NCT01389973 |
Completed |
Janssen Research & Development, LLC |
2013-06-30 |
| NCT01387061 |
Resection for Multiple Hepatocellular Carcinomas (HCC) |
https://ClinicalTrials.gov/show/NCT01387061 |
Completed |
University of Milan |
2011-06-30 |
| NCT01379469 |
Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency |
https://ClinicalTrials.gov/show/NCT01379469 |
Recruiting |
Washington University School of Medicine |
2021-01-31 |
| NCT01370161 |
Early TIPS With Polytetrafluoroethylene (PTFE) Covered Stents for Acute Variceal Bleeding in Patients With Advanced Cirrhosis |
https://ClinicalTrials.gov/show/NCT01370161 |
Completed |
Fourth Military Medical University |
2018-09-30 |
| NCT01359462 |
Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis |
https://ClinicalTrials.gov/show/NCT01359462 |
Completed |
Otsuka Beijing Research Institute |
2009-11-30 |
| NCT01349348 |
Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites |
https://ClinicalTrials.gov/show/NCT01349348 |
Completed |
Otsuka Beijing Research Institute |
2012-05-31 |
| NCT01342250 |
Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01342250 |
Completed |
Shenzhen Beike Bio-Technology Co., Ltd. |
2011-07-31 |
| NCT01333228 |
Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01333228 |
Completed |
Clinica Universidad de Navarra, Universidad de Navarra |
2014-10-31 |
| NCT04421924 |
Periinterventional Coagulation Management of Patients Undergoing a TIPS |
https://ClinicalTrials.gov/show/NCT04421924 |
Recruiting |
Medical University of Graz |
2022-05-31 |
| NCT04414956 |
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT04414956 |
Recruiting |
Korea University |
2023-06-30 |
| NCT04399512 |
Oral Health Status in Patients With Cirrhosis and Effect of Dental Treatment on MELD Score of Cirrhosis Patients |
https://ClinicalTrials.gov/show/NCT04399512 |
Recruiting |
Postgraduate Institute of Dental Sciences Rohtak |
2021-04-30 |
| NCT04397289 |
Anticoagulation Therapy After Splenectomy in Cirrhosis Patient |
https://ClinicalTrials.gov/show/NCT04397289 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2021-03-31 |
| NCT04383951 |
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis |
https://ClinicalTrials.gov/show/NCT04383951 |
Recruiting |
Indiana University |
2024-12-31 |
| NCT04358016 |
Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal Bleeding |
https://ClinicalTrials.gov/show/NCT04358016 |
Completed |
Changhai Hospital |
2020-01-01 |
| NCT04322201 |
Continuous Passive Paracentesis for Intra-abdominal Hypertension |
https://ClinicalTrials.gov/show/NCT04322201 |
Recruiting |
Centro Hospitalar de Lisboa Central |
2021-11-30 |
| NCT04288323 |
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT04288323 |
Recruiting |
University of California, San Diego |
2021-12-31 |
| NCT04281784 |
Project to Improve Communication About Serious Illness–Hospital Study: Pragmatic Trial (Trial 1) |
https://ClinicalTrials.gov/show/NCT04281784 |
Recruiting |
University of Washington |
2021-09-01 |
| NCT04252794 |
Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation |
https://ClinicalTrials.gov/show/NCT04252794 |
Enrolling by invitation |
Institute of Liver and Biliary Sciences, India |
2021-01-31 |
| NCT04243681 |
Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04243681 |
Recruiting |
Asian Institute of Gastroenterology, India |
2020-06-01 |
| NCT04216784 |
Comparison of Diuretic Effect With Furosemide Alone Versus the Combination of Furosemide and Albumin in Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT04216784 |
Recruiting |
Rush University Medical Center |
2020-11-30 |
| NCT04212286 |
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC |
https://ClinicalTrials.gov/show/NCT04212286 |
Recruiting |
Tianjin Third Central Hospital |
2021-12-31 |
| NCT04212273 |
Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC |
https://ClinicalTrials.gov/show/NCT04212273 |
Recruiting |
Tianjin Third Central Hospital |
2021-12-24 |
| NCT04205396 |
CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04205396 |
Recruiting |
University of Michigan |
2022-12-31 |
| NCT04196998 |
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04196998 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2023-12-31 |
| NCT04195971 |
Dual Arterial Phase Liver CT in Patients With Suspected Portal Hypertension |
https://ClinicalTrials.gov/show/NCT04195971 |
Recruiting |
Seoul National University Hospital |
2020-12-31 |
| NCT04191369 |
EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients. |
https://ClinicalTrials.gov/show/NCT04191369 |
Recruiting |
Instituto Ecuatoriano de Enfermedades Digestivas |
2020-11-01 |
| NCT04160039 |
Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit |
https://ClinicalTrials.gov/show/NCT04160039 |
Recruiting |
Medical College of Wisconsin |
2020-12-31 |
| NCT04149223 |
Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation Trial |
https://ClinicalTrials.gov/show/NCT04149223 |
Recruiting |
University of Alberta |
2021-06-01 |
| NCT04140578 |
Antibiotic Prophylaxis in Patients Undergoing GVO |
https://ClinicalTrials.gov/show/NCT04140578 |
Recruiting |
Taipei Veterans General Hospital, Taiwan |
2030-12-31 |
| NCT04113629 |
Simplified Monitoring Myanmar SM2 Study |
https://ClinicalTrials.gov/show/NCT04113629 |
Recruiting |
Kirby Institute |
2020-12-22 |
| NCT04111133 |
Ivabradine in Cirrhotic Cardiomyopathy |
https://ClinicalTrials.gov/show/NCT04111133 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2021-10-31 |
| NCT04099407 |
Pirfenidone and Advanced Liver Fibrosis. |
https://ClinicalTrials.gov/show/NCT04099407 |
Recruiting |
Grupo Mexicano para el Estudios de las Enfermedades Hepaticas |
2020-08-31 |
| NCT04089878 |
"To Study the Impact of Balloon-occluded Retrograde Transvenous Obliteration (BRTO)/Plug Assisted Retrograde Transvenous Obliteration (PARTO) Mediated Portal Flow Modulation in Reduction of Ammonia and Improvement in Organ Volume and Functionality in Patients of Cirrhosis With LR Shunt |
https://ClinicalTrials.gov/show/NCT04089878 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2020-09-30 |
| NCT04088058 |
A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT04088058 |
Recruiting |
Gwo Xi Stem Cell Applied Technology Co., Ltd. |
2021-10-31 |
| NCT04082780 |
Rifamycin in Minimal Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT04082780 |
Recruiting |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2020-09-15 |
| NCT04073290 |
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose |
https://ClinicalTrials.gov/show/NCT04073290 |
Recruiting |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2022-09-30 |
| NCT04072601 |
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT04072601 |
Recruiting |
Copenhagen University Hospital, Hvidovre |
2022-12-31 |
| NCT04058613 |
Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites |
https://ClinicalTrials.gov/show/NCT04058613 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2020-08-08 |
| NCT04048876 |
Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Stage 3 or Stage 4 Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT04048876 |
Recruiting |
Celgene |
2022-07-06 |
| NCT04047160 |
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I) |
https://ClinicalTrials.gov/show/NCT04047160 |
Recruiting |
Komagome Hospital |
2021-03-31 |
| NCT04041115 |
Effect of Non-alcoholic Beer in Cirrhosis |
https://ClinicalTrials.gov/show/NCT04041115 |
Active, not recruiting |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2018-12-31 |
| NCT04013074 |
Efficacy and Safety of Early TIPS (Transjugular Intrahepatic Portosystemic Shunts) in the Management of Cirrhosis With Recurrent Ascites. |
https://ClinicalTrials.gov/show/NCT04013074 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2020-07-31 |
| NCT04012021 |
EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI |
https://ClinicalTrials.gov/show/NCT04012021 |
Recruiting |
University of Pisa |
2020-01-31 |
| NCT03995251 |
Efficacy and Safety of Testosterone Therapy in Improving Sarcopenia in Men With Cirrhosis. |
https://ClinicalTrials.gov/show/NCT03995251 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2020-06-30 |
| NCT03175731 |
PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors) |
https://ClinicalTrials.gov/show/NCT03175731 |
Completed |
Qilu Hospital of Shandong University |
2019-08-30 |
| NCT03969186 |
Telehealth Intervention in Cirrhotics |
https://ClinicalTrials.gov/show/NCT03969186 |
Active, not recruiting |
University of Pennsylvania |
2020-07-31 |
| NCT03969017 |
Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients |
https://ClinicalTrials.gov/show/NCT03969017 |
Recruiting |
Sun Yat-sen University |
2022-05-30 |
| NCT03957629 |
Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03957629 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2021-07-30 |
| NCT03945487 |
Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03945487 |
Recruiting |
Beijing 302 Hospital |
2021-12-30 |
| NCT03932552 |
Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol) |
https://ClinicalTrials.gov/show/NCT03932552 |
Active, not recruiting |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2018-12-31 |
| NCT03920605 |
Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03920605 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2021-10-30 |
| NCT03919565 |
Optimized Treatment of Peginterferon Alfa 2a/2b in Anti-virus Treatment Naive Patients With HBV Related Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03919565 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2021-10-31 |
| NCT03911037 |
GCSF Therapy in Decompensated Cirrhosis - A Double Blinded RCT |
https://ClinicalTrials.gov/show/NCT03911037 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2020-06-30 |
| NCT03892070 |
Beta-Hydroxy-Beta-Methylbutyrate Supplementation and Physical Activity in Liver Cirrhosis: a Controlled Trial |
https://ClinicalTrials.gov/show/NCT03892070 |
Recruiting |
University of Roma La Sapienza |
2019-12-10 |
| NCT03868397 |
Preoperative Portal and Splanchnic Flow Measurement Using MRI |
https://ClinicalTrials.gov/show/NCT03868397 |
Active, not recruiting |
Seoul National University Hospital |
2020-08-31 |
| NCT03864276 |
The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT03864276 |
Recruiting |
Yonsei University |
2020-10-31 |
| NCT03863730 |
Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota |
https://ClinicalTrials.gov/show/NCT03863730 |
Recruiting |
Odense University Hospital |
2021-07-31 |
| NCT03855956 |
Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT03855956 |
Completed |
Kaleido Biosciences |
2019-10-01 |
| NCT03846843 |
OCR002-SP103 - Oral Immediate Release Study |
https://ClinicalTrials.gov/show/NCT03846843 |
Completed |
Mallinckrodt |
2017-11-30 |
| NCT03838250 |
Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC |
https://ClinicalTrials.gov/show/NCT03838250 |
Recruiting |
Pharmicell Co., Ltd. |
2021-03-31 |
| NCT03827681 |
To Study the Efficacy and Safety of TIPS (Trans Intrahepatic Portosystemic Shunt) Versus Self Expanding Metallic Stent (SEMS) in the Management of Refractory Variceal Bleed in Cirrhotics. |
https://ClinicalTrials.gov/show/NCT03827681 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2020-06-30 |
| NCT03827200 |
A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03827200 |
Recruiting |
Noorik Biopharmaceuticals AG |
2020-09-30 |
| NCT03809052 |
A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GB1211 in Healthy Subjects and in Subjects With Suspected Non-Alcoholic Steato-Hepatitis (NASH) and Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03809052 |
Recruiting |
Galecto Biotech AB |
2020-01-31 |
| NCT03798119 |
TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR) |
https://ClinicalTrials.gov/show/NCT03798119 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2020-08-31 |
| NCT03796598 |
FMT in Cirrhosis and Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT03796598 |
Recruiting |
VA Office of Research and Development |
2023-06-01 |
| NCT03780673 |
Efficacy of the Combination of Simvastatin Plus Rifaximin in Patients With Decompensated Cirrhosis to Prevent ACLF Development |
https://ClinicalTrials.gov/show/NCT03780673 |
Recruiting |
Institut d’Investigacions Biomèdiques August Pi i Sunyer |
2021-12-31 |
| NCT03776955 |
Beta-blockers for Oesophageal Varices |
https://ClinicalTrials.gov/show/NCT03776955 |
Recruiting |
King’s College Hospital NHS Trust |
2024-09-30 |
| NCT03759158 |
N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial |
https://ClinicalTrials.gov/show/NCT03759158 |
Completed |
Institute of Liver and Biliary Sciences, India |
2019-01-15 |
| NCT03748563 |
DS-MCE vs EGD for Diagnosing Gastroesophageal Varices |
https://ClinicalTrials.gov/show/NCT03748563 |
Recruiting |
Changhai Hospital |
2019-12-31 |
| NCT03736265 |
Carvedilol for Prevention of Esophageal Varices Progression |
https://ClinicalTrials.gov/show/NCT03736265 |
Recruiting |
Beijing Friendship Hospital |
2020-12-30 |
| NCT03725631 |
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD |
https://ClinicalTrials.gov/show/NCT03725631 |
Recruiting |
Korea University Guro Hospital |
2019-08-31 |
| NCT03721952 |
Facilitating Communication Study |
https://ClinicalTrials.gov/show/NCT03721952 |
Recruiting |
University of Washington |
2022-10-31 |
| NCT03712280 |
MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) |
https://ClinicalTrials.gov/show/NCT03712280 |
Recruiting |
Mallinckrodt |
2020-08-31 |
| NCT03695705 |
Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT03695705 |
Completed |
Postgraduate Institute of Medical Education and Research |
2016-12-31 |
| NCT03694691 |
Developing Viability Index for Machine Perfused Livers |
https://ClinicalTrials.gov/show/NCT03694691 |
Recruiting |
Massachusetts General Hospital |
2021-10-01 |
| NCT03673215 |
The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment |
https://ClinicalTrials.gov/show/NCT03673215 |
Recruiting |
Shenyang Sunshine Pharmaceutical Co., LTD. |
2020-10-08 |
| NCT03659058 |
Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR |
https://ClinicalTrials.gov/show/NCT03659058 |
Completed |
Zagazig University |
2018-08-31 |
| NCT03656068 |
An Evaluation of the Safety and Efficacy of NTZ on Collagen Turnover in NASH Patients With Fibrosis |
https://ClinicalTrials.gov/show/NCT03656068 |
Recruiting |
Pinnacle Clinical Research, PLLC |
2019-12-31 |
| NCT03637959 |
Liver Fibrosis Evaluation Using Ultrasound Shear Wave Imaging |
https://ClinicalTrials.gov/show/NCT03637959 |
Enrolling by invitation |
Mayo Clinic |
2021-12-31 |
| NCT03633279 |
Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C |
https://ClinicalTrials.gov/show/NCT03633279 |
Recruiting |
Dayanand Medical College and Hospital |
2020-06-30 |
| NCT03633227 |
Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment |
https://ClinicalTrials.gov/show/NCT03633227 |
Recruiting |
Intercept Pharmaceuticals |
2022-12-01 |
| NCT03626090 |
Mesenchymal Stem Cell Therapy for Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03626090 |
Recruiting |
Stem Med Pte. Ltd. |
2020-10-22 |
| NCT03625726 |
Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE) |
https://ClinicalTrials.gov/show/NCT03625726 |
Recruiting |
University Hospital, Clermont-Ferrand |
2020-08-31 |
| NCT03624517 |
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices |
https://ClinicalTrials.gov/show/NCT03624517 |
Recruiting |
Medical University of South Carolina |
2020-12-31 |
| NCT03620474 |
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03620474 |
Recruiting |
Komagome Hospital |
2020-11-30 |
| NCT03612973 |
Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT03612973 |
Recruiting |
Assiut University |
2021-10-31 |
| NCT03605147 |
The Effect of Calcium β-hydroxy-β-methylbutyrate (CaHMB) Supplementation in Sarcopenia in Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03605147 |
Recruiting |
Shanghai Zhongshan Hospital |
2019-07-31 |
| NCT03568578 |
A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers |
https://ClinicalTrials.gov/show/NCT03568578 |
Recruiting |
Peking University First Hospital |
2020-12-31 |
| NCT03566914 |
Tadalafil for Erectile Dysfunction in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT03566914 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2020-06-30 |
| NCT03564626 |
Health IT Generated PROs to Improve Outcomes in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03564626 |
Enrolling by invitation |
Virginia Commonwealth University |
2022-06-20 |
| NCT03559166 |
First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03559166 |
Completed |
Blade Therapeutics |
2019-10-04 |
| NCT03547895 |
Management of Decompensated HCV Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT03547895 |
Completed |
Zagazig University |
2016-05-24 |
| NCT03534141 |
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation |
https://ClinicalTrials.gov/show/NCT03534141 |
Recruiting |
University of California, San Francisco |
2020-06-30 |
| NCT03517540 |
Safety, Tolerability, and Efficacy of a Combination Treatment of Tropifexor (LJN452) and Cenicriviroc (CVC) in Adult Patients With Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis. (TANDEM) |
https://ClinicalTrials.gov/show/NCT03517540 |
Recruiting |
Novartis |
2020-08-28 |
| NCT03493204 |
Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial |
https://ClinicalTrials.gov/show/NCT03493204 |
Completed |
University of Michigan |
2019-08-19 |
| NCT03486912 |
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03486912 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-09-17 |
| NCT03486899 |
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03486899 |
Active, not recruiting |
Bristol-Myers Squibb |
2020-04-28 |
| NCT03470389 |
Establishment and Assessment of the HVPG Using Biofluid Mechanics (HVPGBFM) |
https://ClinicalTrials.gov/show/NCT03470389 |
Recruiting |
Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University |
2020-09-30 |
| NCT03451292 |
Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites |
https://ClinicalTrials.gov/show/NCT03451292 |
Recruiting |
Grifols Therapeutics LLC |
2021-10-31 |
| NCT03447730 |
Safety, Tolerability and Pharmacodynamics of SYNB1020 |
https://ClinicalTrials.gov/show/NCT03447730 |
Completed |
Synlogic |
2019-08-20 |
| NCT03445208 |
A Study of Experimental Medication BMS-986036 Given to Healthy Participants |
https://ClinicalTrials.gov/show/NCT03445208 |
Completed |
Bristol-Myers Squibb |
2018-05-02 |
| NCT03439254 |
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis |
https://ClinicalTrials.gov/show/NCT03439254 |
Active, not recruiting |
Intercept Pharmaceuticals |
2021-06-30 |
| NCT03437876 |
Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis |
https://ClinicalTrials.gov/show/NCT03437876 |
Recruiting |
Zhongshan Hospital Xiamen University |
2020-11-30 |
| NCT03420768 |
A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C |
https://ClinicalTrials.gov/show/NCT03420768 |
Completed |
Bristol-Myers Squibb |
2018-12-10 |
| NCT03416751 |
Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03416751 |
Completed |
Hunter Holmes Mcguire Veteran Affairs Medical Center |
2020-04-10 |
| NCT01265173 |
Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC |
https://ClinicalTrials.gov/show/NCT01265173 |
Completed |
Korea University |
2018-06-30 |
| NCT01249092 |
Pentoxifylline for Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT01249092 |
Completed |
The Cleveland Clinic |
2012-06-30 |
| NCT00006166 |
North American Study for the Treatment of Refractory Ascites (NASTRA) |
https://ClinicalTrials.gov/show/NCT00006166 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT01231685 |
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection |
https://ClinicalTrials.gov/show/NCT01231685 |
Completed |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2016-03-31 |
| NCT01220492 |
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01220492 |
Completed |
Beijing 302 Hospital |
2016-04-30 |
| NCT01212250 |
Carvedilol for Pre-primary Prophylaxis of Esophageal Varices in Cirrhosis |
https://ClinicalTrials.gov/show/NCT01212250 |
Recruiting |
Institute of Liver and Biliary Sciences, India |
2020-12-01 |
| NCT01201720 |
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With “Acute-on-chronic Liver Failure” |
https://ClinicalTrials.gov/show/NCT01201720 |
Completed |
Grifols Therapeutics LLC |
2013-01-31 |
| NCT01196507 |
Early Primary Prophylaxis of Esophageal Varices |
https://ClinicalTrials.gov/show/NCT01196507 |
Completed |
Institute of Liver and Biliary Sciences, India |
2014-04-30 |
| NCT01165073 |
Short Term Feeding for Asian Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT01165073 |
Completed |
University of Malaya |
2009-05-31 |
| NCT03872024 |
Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients |
https://ClinicalTrials.gov/show/NCT03872024 |
Recruiting |
Echosens |
2020-12-31 |
| NCT01157845 |
Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT01157845 |
Completed |
Virginia Commonwealth University |
2012-07-31 |
| NCT01150916 |
B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites |
https://ClinicalTrials.gov/show/NCT01150916 |
Completed |
University of Sao Paulo |
2011-11-30 |
| NCT01147380 |
Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation |
https://ClinicalTrials.gov/show/NCT01147380 |
Completed |
University of Miami |
2014-12-31 |
| NCT01135628 |
Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT01135628 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2014-05-31 |
| NCT01133795 |
Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment |
https://ClinicalTrials.gov/show/NCT01133795 |
Completed |
Hospital Clinic of Barcelona |
2016-06-30 |
| NCT01120925 |
Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT01120925 |
Completed |
Royan Institute |
2013-07-31 |
| NCT01113814 |
Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV |
https://ClinicalTrials.gov/show/NCT01113814 |
Completed |
Johann Wolfgang Goethe University Hospital |
NA |
| NCT01095185 |
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding |
https://ClinicalTrials.gov/show/NCT01095185 |
Completed |
Hospital Clinic of Barcelona |
2013-09-30 |
| NCT01082419 |
Acoustic Radiation Force Impulse Imaging (ARFI) : a New Technique to Assess Liver Elasticity |
https://ClinicalTrials.gov/show/NCT01082419 |
Completed |
University Hospital, Bordeaux |
2013-04-30 |
| NCT01080144 |
Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal Encephalopathy |
https://ClinicalTrials.gov/show/NCT01080144 |
Completed |
University Hospital, Toulouse |
2012-10-31 |
| NCT01072721 |
Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis |
https://ClinicalTrials.gov/show/NCT01072721 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-07-11 |
| NCT01062750 |
Liver Regeneration Therapy by Intrahepatic Arterial Administration of Autologous Adipose Tissue Derived Stromal Cells |
https://ClinicalTrials.gov/show/NCT01062750 |
Completed |
Kanazawa University |
2015-02-28 |
| NCT02022137 |
Fructans, Lactitol and Lactose in Minimal Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT02022137 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2015-08-31 |
| NCT01045525 |
Phlebotomy and Lifestyle and Diet Advices vs Lifestyle and Diet Advices Only in Patients With Dysmetabolic Liversiderosis |
https://ClinicalTrials.gov/show/NCT01045525 |
Completed |
Rennes University Hospital |
2015-06-30 |
| NCT01013194 |
Human Fetal Liver Cell Transplantation in Chronic Liver Failure |
https://ClinicalTrials.gov/show/NCT01013194 |
Completed |
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies |
2011-04-30 |
| NCT01006031 |
Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 |
https://ClinicalTrials.gov/show/NCT01006031 |
Completed |
Sociedad Andaluza de Enfermedades Infecciosas |
2011-12-31 |
| NCT00999167 |
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT00999167 |
Completed |
Horizon Pharma Ireland, Ltd., Dublin Ireland |
2012-04-30 |
| NCT00990639 |
Effect of Candesartan in Alcoholic Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT00990639 |
Completed |
Yonsei University |
2008-12-31 |
| NCT00968695 |
Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. |
https://ClinicalTrials.gov/show/NCT00968695 |
Completed |
Grifols Therapeutics LLC |
2014-04-30 |
| NCT00965900 |
Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding |
https://ClinicalTrials.gov/show/NCT00965900 |
Recruiting |
Korea University |
2019-05-31 |
| NCT00965744 |
A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension |
https://ClinicalTrials.gov/show/NCT00965744 |
Completed |
Shanghai Changzheng Hospital |
2008-12-31 |
| NCT00006164 |
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment |
https://ClinicalTrials.gov/show/NCT00006164 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2007-04-30 |
| NCT00956098 |
Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis |
https://ClinicalTrials.gov/show/NCT00956098 |
Completed |
CJ HealthCare Corporation |
NA |
| NCT00955500 |
Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy |
https://ClinicalTrials.gov/show/NCT00955500 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2008-01-31 |
| NCT00943176 |
Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC) |
https://ClinicalTrials.gov/show/NCT00943176 |
Completed |
Mayo Clinic |
2011-04-30 |
| NCT00921349 |
A Trial of Ligation Plus Nadolol Versus Nadolol Alone in the Prophylaxis of First Variceal Bleeding in Cirrhosis |
https://ClinicalTrials.gov/show/NCT00921349 |
Completed |
National Science Council, Taiwan |
2009-05-31 |
| NCT00896597 |
Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT00896597 |
Completed |
Norgine |
2009-12-31 |
| NCT00896233 |
Magnetic Resonance Elastography for Assessment of Liver Fibrosis (MK-0000-132)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00896233 |
Completed |
Merck Sharp & Dohme Corp. |
2010-01-31 |
| NCT00886925 |
Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT00886925 |
Completed |
Hospital Universitari Vall d’Hebron Research Institute |
2012-07-31 |
| NCT00885313 |
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) |
https://ClinicalTrials.gov/show/NCT00885313 |
Completed |
Bambino Gesù Hospital and Research Institute |
2010-04-30 |
| NCT00857480 |
Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin |
https://ClinicalTrials.gov/show/NCT00857480 |
Completed |
Norgine |
2006-08-31 |
| NCT00856869 |
Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00856869 |
Completed |
Norgine |
2005-02-28 |
| NCT00856713 |
Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00856713 |
Completed |
Norgine |
2006-08-31 |
| NCT00844402 |
Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00844402 |
Completed |
Medical University of Graz |
2007-11-30 |
| NCT02021253 |
Influence of Probiotics Administration Before Liver Resection in Liver Disease |
https://ClinicalTrials.gov/show/NCT02021253 |
Completed |
University Hospital, Rouen |
2018-04-12 |
| NCT04178096 |
Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care |
https://ClinicalTrials.gov/show/NCT04178096 |
Enrolling by invitation |
VA Office of Research and Development |
2022-09-30 |
| NCT04113317 |
Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation |
https://ClinicalTrials.gov/show/NCT04113317 |
Enrolling by invitation |
Fakultas Kedokteran Universitas Indonesia |
2021-09-16 |
| NCT00831337 |
Evaluation of Probiotics in the Treatment of Portal Hypertension |
https://ClinicalTrials.gov/show/NCT00831337 |
Completed |
Pomeranian Medical University Szczecin |
2010-11-30 |
| NCT04195724 |
Microbiome Translocation in Different Circulatory Compartments in Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04195724 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2020-12-31 |
| NCT02787772 |
Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? |
https://ClinicalTrials.gov/show/NCT02787772 |
Completed |
University of Sao Paulo General Hospital |
2014-11-30 |
| NCT02514434 |
Usefulness of Non-contrast MagnetIc Resonance imAging Versus Non-Contrast Ultrasonography for surveiLlancE of HepatoCellular Carcinoma [MIRACLE-HCC] |
https://ClinicalTrials.gov/show/NCT02514434 |
Active, not recruiting |
Yonsei University |
2022-12-31 |
| NCT01188733 |
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT01188733 |
Completed |
Mayo Clinic |
2000-07-31 |
| NCT00816127 |
Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction |
https://ClinicalTrials.gov/show/NCT00816127 |
Completed |
Icahn School of Medicine at Mount Sinai |
2007-05-31 |
| NCT01995071 |
A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV) |
https://ClinicalTrials.gov/show/NCT01995071 |
Completed |
AbbVie |
2015-06-30 |
| NCT04330469 |
Periodontal Therapy and Oral-gut-hepatic Axis Cirrhosis: a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT04330469 |
Recruiting |
Postgraduate Institute of Medical Education and Research |
2021-03-30 |
| NCT01349335 |
Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites |
https://ClinicalTrials.gov/show/NCT01349335 |
Completed |
Otsuka Beijing Research Institute |
2010-01-31 |
| NCT00805805 |
Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00805805 |
Completed |
University of Michigan |
2008-12-31 |
| NCT03028740 |
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH |
https://ClinicalTrials.gov/show/NCT03028740 |
Recruiting |
Tobira Therapeutics, Inc. |
2021-10-14 |
| NCT03770936 |
Effect of Some Drugs on Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT03770936 |
Recruiting |
Tanta University |
2026-10-31 |
| NCT03731923 |
Abbreviated MRI for HCC Surveillance |
https://ClinicalTrials.gov/show/NCT03731923 |
Recruiting |
Seoul National University Hospital |
2021-12-31 |
| NCT03080129 |
Microbiome and Sarcopenia in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03080129 |
Recruiting |
Medical University of Graz |
2021-07-31 |
| NCT03209986 |
Trial of Mesenchymal Stem Cell Transplantation in Decompensated Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT03209986 |
Recruiting |
Xijing Hospital of Digestive Diseases |
2019-06-30 |
| NCT03091738 |
Ramelteon for Treatment of Insomnia in Cirrhosis |
https://ClinicalTrials.gov/show/NCT03091738 |
Completed |
Virginia Commonwealth University |
2018-10-01 |
| NCT02682108 |
Diffusion-weighted Imaging Magnetic Resonance for Assessing Liver Fibrosis |
https://ClinicalTrials.gov/show/NCT02682108 |
Completed |
Mahidol University |
2016-06-30 |
| NCT02642432 |
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT02642432 |
Completed |
AbbVie |
2016-10-27 |
| NCT02744105 |
Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C |
https://ClinicalTrials.gov/show/NCT02744105 |
Completed |
Tanta University |
2017-12-31 |
| NCT02298868 |
Safety and Efficacy of Baclofen for Treatment of Muscle Spasms in Patients With Cirrhosis: A Pilot Study |
https://ClinicalTrials.gov/show/NCT02298868 |
Completed |
University of Virginia |
2013-11-30 |
| NCT02207088 |
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT02207088 |
Completed |
AbbVie |
2016-12-06 |
| NCT02178319 |
Laparoscopic Versus Open Devascularization for Portal Hypertension, a Randomized Controlled Trial |
https://ClinicalTrials.gov/show/NCT02178319 |
Recruiting |
Second Affiliated Hospital of Xi’an Jiaotong University |
2021-06-30 |
| NCT04357600 |
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B |
https://ClinicalTrials.gov/show/NCT04357600 |
Recruiting |
PT. Prodia Stem Cell Indonesia |
2020-12-20 |
| NCT04210245 |
Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) |
https://ClinicalTrials.gov/show/NCT04210245 |
Recruiting |
NGM Biopharmaceuticals, Inc |
2022-06-30 |
| NCT04073693 |
Characterization of the Nutritional Status in the Patient With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT04073693 |
Completed |
Puerta de Hierro University Hospital |
2019-08-01 |
| NCT00772057 |
Beta-blockers for Prevention Of Growth Of Small Esophageal Varices In Cirrhosis: An Randomized Controlled Trial (RCT) |
https://ClinicalTrials.gov/show/NCT00772057 |
Completed |
Govind Ballabh Pant Hospital |
2008-10-31 |
| NCT00764049 |
Single Pass Albumin Dialysis in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT00764049 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2012-01-31 |
| NCT00741663 |
Spironolactone Versus Spironolactone Plus Furosemide (SVSSF) |
https://ClinicalTrials.gov/show/NCT00741663 |
Completed |
University of Padova |
2008-09-30 |
| NCT00736840 |
BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis |
https://ClinicalTrials.gov/show/NCT00736840 |
Completed |
Exalenz Bioscience LTD. |
2009-09-30 |
| NCT00713934 |
Autologous Bone Marrow Stem Cells in Cirrhosis Patients |
https://ClinicalTrials.gov/show/NCT00713934 |
Completed |
Royan Institute |
2009-01-31 |
| NCT00701792 |
Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis |
https://ClinicalTrials.gov/show/NCT00701792 |
Completed |
Centre Hospitalier Universitaire de Besancon |
2006-11-30 |
| NCT00698464 |
Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function |
https://ClinicalTrials.gov/show/NCT00698464 |
Completed |
Novartis |
2009-04-30 |
| NCT00689754 |
Efficacy and Safety Study on Nasogastric (NG) Tube in Patients With Upper Gastrointestinal Bleed |
https://ClinicalTrials.gov/show/NCT00689754 |
Completed |
University of Texas Southwestern Medical Center |
2011-08-31 |
| NCT00687219 |
Efficacy and Safety of Peginterferon Alfa-2b and Ribavirin Therapy in Subjects With Type C Compensated Liver Cirrhosis (Study P05116) |
https://ClinicalTrials.gov/show/NCT00687219 |
Completed |
Merck Sharp & Dohme Corp. |
2010-10-31 |
| NCT02078882 |
Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT02078882 |
Completed |
University of California, Davis |
2018-10-31 |
| NCT00628160 |
Terlipressin in Septic Shock in Cirrhosis |
https://ClinicalTrials.gov/show/NCT00628160 |
Completed |
Hospital Clinic of Barcelona |
2012-12-31 |
| NCT00594191 |
Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension |
https://ClinicalTrials.gov/show/NCT00594191 |
Completed |
Hospital Clinic of Barcelona |
2007-04-30 |
| NCT00592475 |
A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic Patients |
https://ClinicalTrials.gov/show/NCT00592475 |
Completed |
Cumberland Pharmaceuticals |
2008-11-30 |
| NCT00588302 |
Moexipril for Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00588302 |
Completed |
Mayo Clinic |
2007-06-30 |
| NCT00575042 |
Use of Fenofibrate for Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00575042 |
Completed |
University of Florida |
2009-08-31 |
| NCT00570765 |
Study of INT-747 as Monotherapy in Patients With PBC |
https://ClinicalTrials.gov/show/NCT00570765 |
Completed |
Intercept Pharmaceuticals |
2010-09-30 |
| NCT00570622 |
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis |
https://ClinicalTrials.gov/show/NCT00570622 |
Completed |
Medical University of Vienna |
2008-11-30 |
| NCT00562783 |
A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT00562783 |
Completed |
Hospital Authority, Hong Kong |
NA |
| NCT00820781 |
Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices |
https://ClinicalTrials.gov/show/NCT00820781 |
Completed |
University of California, San Diego |
1977-12-31 |
| NCT00550862 |
Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC) |
https://ClinicalTrials.gov/show/NCT00550862 |
Completed |
Intercept Pharmaceuticals |
2009-08-31 |
| NCT00525252 |
Efficacy of Baclofen in the Treatment of Alcohol Addiction |
https://ClinicalTrials.gov/show/NCT00525252 |
Completed |
Catholic University of the Sacred Heart |
NA |
| NCT00502086 |
Efficacy and Safety of Viusid in Patients With Hepatic Cirrhosis Secondary to Hepatitis C Virus Infection. |
https://ClinicalTrials.gov/show/NCT00502086 |
Completed |
Catalysis SL |
2009-07-31 |
| NCT00501722 |
Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites |
https://ClinicalTrials.gov/show/NCT00501722 |
Completed |
Sanofi |
2005-03-31 |
| NCT00501566 |
Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites |
https://ClinicalTrials.gov/show/NCT00501566 |
Completed |
Sanofi |
NA |
| NCT00501384 |
Satavaptan Dose-Ranging Study in the Prevention of Ascites |
https://ClinicalTrials.gov/show/NCT00501384 |
Completed |
Sanofi |
2005-05-31 |
| NCT00490620 |
Study of Combivir for Patients With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00490620 |
Completed |
University of Alberta |
NA |
| NCT00469131 |
Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid |
https://ClinicalTrials.gov/show/NCT00469131 |
Completed |
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan |
2010-08-31 |
| NCT00420134 |
Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial |
https://ClinicalTrials.gov/show/NCT00420134 |
Completed |
Shahid Beheshti University of Medical Sciences |
2009-05-31 |
| NCT00406237 |
Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00406237 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2009-03-31 |
| NCT00378599 |
Effects of Pegylated Interferon Alfa-2b and Ribavirin After Orthotopic Liver Transplantation in Subjects With Chronic Hepatitis C Recurrence (P04590AM3)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00378599 |
Completed |
Merck Sharp & Dohme Corp. |
2009-07-31 |
| NCT00926224 |
Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients |
https://ClinicalTrials.gov/show/NCT00926224 |
Completed |
Echosens |
2010-07-31 |
| NCT00364819 |
Initial Study of Rituximab to Treat Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00364819 |
Completed |
University of California, Davis |
2009-07-31 |
| NCT00359853 |
Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis |
https://ClinicalTrials.gov/show/NCT00359853 |
Completed |
Hospital Clinic of Barcelona |
NA |
| NCT00358878 |
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) |
https://ClinicalTrials.gov/show/NCT00358878 |
Completed |
Sanofi |
2008-12-31 |
| NCT00347009 |
Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis |
https://ClinicalTrials.gov/show/NCT00347009 |
Completed |
GlaxoSmithKline |
2009-09-30 |
| NCT00344916 |
Phase 1 Study of L-NMMA in Patients With Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT00344916 |
Completed |
Regional Hospital Holstebro |
NA |
| NCT00323804 |
Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy. |
https://ClinicalTrials.gov/show/NCT00323804 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2013-02-28 |
| NCT00312910 |
Probiotics for the Prevention of Major Complications of Cirrhosis |
https://ClinicalTrials.gov/show/NCT00312910 |
Completed |
Meir Medical Center |
NA |
| NCT00304551 |
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) |
https://ClinicalTrials.gov/show/NCT00304551 |
Completed |
Chugai Pharmaceutical |
2009-12-31 |
| NCT00301509 |
Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis |
https://ClinicalTrials.gov/show/NCT00301509 |
Completed |
Casa Sollievo della Sofferenza IRCCS |
NA |
| NCT00298714 |
Effects of Losartan on Hepatic Fibrogenesis in Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00298714 |
Completed |
Hospital Clinic of Barcelona |
NA |
| NCT00296244 |
Steroid Free Immunosuppression in Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00296244 |
Completed |
Thomas Jefferson University |
2008-05-31 |
| NCT00287235 |
Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) |
https://ClinicalTrials.gov/show/NCT00287235 |
Completed |
Baxter Healthcare Corporation |
2003-11-30 |
| NCT00275652 |
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. |
https://ClinicalTrials.gov/show/NCT00275652 |
Completed |
Mayo Clinic |
2007-08-31 |
| NCT03468699 |
Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia |
https://ClinicalTrials.gov/show/NCT03468699 |
Recruiting |
Vinmec Research Institute of Stem Cell and Gene Technology |
2019-12-31 |
| NCT00273247 |
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis |
https://ClinicalTrials.gov/show/NCT00273247 |
Completed |
National Cancer Institute, Milan |
NA |
| NCT00252642 |
Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C |
https://ClinicalTrials.gov/show/NCT00252642 |
Completed |
Virginia Commonwealth University |
2007-09-30 |
| NCT00245830 |
Ischemic Preconditioning of Liver in Cadaver Donors |
https://ClinicalTrials.gov/show/NCT00245830 |
Completed |
Rutgers, The State University of New Jersey |
2006-07-31 |
| NCT00244751 |
Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects |
https://ClinicalTrials.gov/show/NCT00244751 |
Completed |
GlaxoSmithKline |
2008-03-13 |
| NCT00244569 |
Development of a Breath Test for Monitoring Patients With Liver Disease |
https://ClinicalTrials.gov/show/NCT00244569 |
Completed |
Virginia Commonwealth University |
2007-04-30 |
| NCT00243633 |
Characterization of Focal Liver Lesions by Real-Time Contrast-Enhanced Ultrasound Imaging (CEUS) |
https://ClinicalTrials.gov/show/NCT00243633 |
Completed |
University Hospital, Tours |
2006-12-31 |
| NCT00232427 |
PiCCO Guided Therapy in Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT00232427 |
Completed |
Heidelberg University |
NA |
| NCT00222014 |
TIPS With Coated Stents for Refractory Ascites in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT00222014 |
Completed |
University Hospital, Toulouse |
2012-12-31 |
| NCT00212186 |
Selenium Supplementation of Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT00212186 |
Completed |
Vanderbilt University |
2003-11-30 |
| NCT00190385 |
Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT00190385 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2009-07-31 |
| NCT00179413 |
Study of Long-term Peg Intron vs. Colchicine in Non-responders. |
https://ClinicalTrials.gov/show/NCT00179413 |
Completed |
Beth Israel Deaconess Medical Center |
2009-12-31 |
| NCT00180674 |
Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00180674 |
Completed |
Imperial College London |
2006-09-30 |
| NCT00168961 |
Enteral Nutrition in Liver Cirrhosis |
https://ClinicalTrials.gov/show/NCT00168961 |
Completed |
Charite University, Berlin, Germany |
2006-12-31 |
| NCT00162552 |
Clinical Trial of Pentoxifylline in Patient With Cirrhosis |
https://ClinicalTrials.gov/show/NCT00162552 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2007-12-31 |
| NCT00154492 |
Use of NovoSeven® in Active Variceal Bleeding |
https://ClinicalTrials.gov/show/NCT00154492 |
Completed |
Novo Nordisk A/S |
2006-08-31 |
| NCT00147043 |
Adult Stem Cell Therapy in Liver Insufficiency |
https://ClinicalTrials.gov/show/NCT00147043 |
Completed |
Imperial College London |
2005-06-30 |
| NCT00124228 |
Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis |
https://ClinicalTrials.gov/show/NCT00124228 |
Completed |
Hospital Clinic of Barcelona |
2008-10-31 |
| NCT00122616 |
Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C |
https://ClinicalTrials.gov/show/NCT00122616 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
2009-03-31 |
| NCT00115947 |
Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites |
https://ClinicalTrials.gov/show/NCT00115947 |
Completed |
Hvidovre University Hospital |
NA |
| NCT00108355 |
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis |
https://ClinicalTrials.gov/show/NCT00108355 |
Completed |
VA Office of Research and Development |
2010-08-31 |
| NCT00076336 |
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis |
https://ClinicalTrials.gov/show/NCT00076336 |
Completed |
Novartis |
2009-12-31 |
| NCT00058903 |
Treatment of Cholestatic Pruritus With Sertraline |
https://ClinicalTrials.gov/show/NCT00058903 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00049842 |
Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00049842 |
Completed |
Merck Sharp & Dohme Corp. |
2009-10-31 |
| NCT00048724 |
Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients With Cirrhosis (Study P02569) |
https://ClinicalTrials.gov/show/NCT00048724 |
Completed |
Merck Sharp & Dohme Corp. |
2008-04-30 |
| NCT00043303 |
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis |
https://ClinicalTrials.gov/show/NCT00043303 |
Completed |
InterMune |
NA |
| NCT00039871 |
PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) |
https://ClinicalTrials.gov/show/NCT00039871 |
Completed |
Merck Sharp & Dohme Corp. |
2007-09-30 |
| NCT00794911 |
Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00794911 |
Completed |
Beth Israel Deaconess Medical Center |
2010-12-31 |
| NCT00794482 |
Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity. |
https://ClinicalTrials.gov/show/NCT00794482 |
Completed |
Norgine |
2009-06-30 |
| NCT00006161 |
Decompression Intervention of Variceal Rebleeding Trial (DIVERT) |
https://ClinicalTrials.gov/show/NCT00006161 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
NA |
| NCT00543426 |
Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis |
https://ClinicalTrials.gov/show/NCT00543426 |
Completed |
Shanghai University of Traditional Chinese Medicine |
2009-05-31 |
| NCT00517738 |
Effect of Physical Training Program on Health-related Quality of Life in Cirrhosis |
https://ClinicalTrials.gov/show/NCT00517738 |
Completed |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2014-01-31 |
| NCT00006398 |
Prevention of Esophageal Varices by Beta-Adrenergic Blockers |
https://ClinicalTrials.gov/show/NCT00006398 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2002-09-30 |
| NCT00004842 |
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis |
https://ClinicalTrials.gov/show/NCT00004842 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
1999-04-30 |
| NCT00004796 |
Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis |
https://ClinicalTrials.gov/show/NCT00004796 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004784 |
Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00004784 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00004748 |
Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis |
https://ClinicalTrials.gov/show/NCT00004748 |
Completed |
Office of Rare Diseases (ORD) |
NA |